We describe a highly unusual case of metastatic melanoma in a 61-year-old female that manifested as a single groin lymph node metastasis accompanied by two distinct, subcutaneous sarcomatoid tumors on the same leg, without evidence of a primary tumor. Characterization encompassed extensive immunohistochemical staining as well as next-generation sequencing (NGS). The lymph node metastasis showed obvious features of melanoma. The two subcutaneous lesions, however, were morphologically and immunohistochemically consistent with high-grade myxofibrosarcoma and soft tissue mixed tumor, respectively. All three lesions were BRAF wild-type and found to harbor an identical NRAS p.Q61R mutation. Metachronic intestinal metastases, showing intermingled ...
Cutaneous malignant melanoma (CMM) is the most lethal form of skin cancer and its incidence has incr...
To reveal the clonal architecture of melanoma and associated driver mutations, whole genome sequenci...
Background Alternative methods are required to optimise the clinical insights that may be derived fr...
We describe a highly unusual case of metastatic melanoma in a 61-year-old female that manifested as ...
Diversity between metastatic melanoma tumours in individual patients is known; however, the molecula...
Melanoma is difficult to treat once it becomes metastatic. However, the precise ancestral relationsh...
To reveal the clonal architecture of melanoma and associated driver mutations, whole genome sequenci...
<div><p>To reveal the clonal architecture of melanoma and associated driver mutations, whole genome ...
BACKGROUND: Cutaneous melanoma can metastasise haematogenously and/or lymphogenously to form satelli...
Background: Metastases represent a small percentage of the malignancies affecting the breast, and on...
Genomic alterations occurring during melanoma progression and the resulting genomic heterogeneity be...
Metastasis is the main cause of cancer patient deaths and remains a poorly characterized process. It...
Item does not contain fulltextMalignant melanomas are known for their remarkable morphological varia...
Abstract: Metastatic melanoma carries a poor prognosis despite modern systemic therapies. Understand...
The management of metastatic melanoma is a difficult matter. Nevertheless, the advent of target ther...
Cutaneous malignant melanoma (CMM) is the most lethal form of skin cancer and its incidence has incr...
To reveal the clonal architecture of melanoma and associated driver mutations, whole genome sequenci...
Background Alternative methods are required to optimise the clinical insights that may be derived fr...
We describe a highly unusual case of metastatic melanoma in a 61-year-old female that manifested as ...
Diversity between metastatic melanoma tumours in individual patients is known; however, the molecula...
Melanoma is difficult to treat once it becomes metastatic. However, the precise ancestral relationsh...
To reveal the clonal architecture of melanoma and associated driver mutations, whole genome sequenci...
<div><p>To reveal the clonal architecture of melanoma and associated driver mutations, whole genome ...
BACKGROUND: Cutaneous melanoma can metastasise haematogenously and/or lymphogenously to form satelli...
Background: Metastases represent a small percentage of the malignancies affecting the breast, and on...
Genomic alterations occurring during melanoma progression and the resulting genomic heterogeneity be...
Metastasis is the main cause of cancer patient deaths and remains a poorly characterized process. It...
Item does not contain fulltextMalignant melanomas are known for their remarkable morphological varia...
Abstract: Metastatic melanoma carries a poor prognosis despite modern systemic therapies. Understand...
The management of metastatic melanoma is a difficult matter. Nevertheless, the advent of target ther...
Cutaneous malignant melanoma (CMM) is the most lethal form of skin cancer and its incidence has incr...
To reveal the clonal architecture of melanoma and associated driver mutations, whole genome sequenci...
Background Alternative methods are required to optimise the clinical insights that may be derived fr...